Investing Ideas
/
Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

17 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
BANB Bachem Holding	CHF 61.15	-6.9%	-5.0%	CHF 4.6b	CHF 83.57	PE40.4x	E17.9%	1.3%
KURN Kuros Biosciences	CHF 20.75	0.5%	470.1%	CHF 779.6m	n/a	PS14.8x	n/a	n/a
MOLN Molecular Partners	CHF 4.63	-6.8%	22.7%	CHF 170.5m	CHF 9.75	PS28.4x	E-1.9%	n/a
COPN Cosmo Pharmaceuticals	CHF 59.10	-3.6%	13.9%	CHF 948.3m	CHF 97.30	PE14.6x	E17.2%	3.2%
TECN Tecan Group	CHF 197.50	-4.9%	-42.7%	CHF 2.5b	CHF 284.86	PE25x	E14.8%	1.5%
SKAN SKAN Group	CHF 74.90	2.5%	-7.4%	CHF 1.7b	CHF 90.67	PE52.2x	E18.7%	0.5%
DESN Dottikon ES Holding	CHF 218.50	-4.0%	-5.8%	CHF 3.0b	CHF 350.00	PE40x	S16.4%	0%
BSLN Basilea Pharmaceutica	CHF 41.60	2.3%	20.2%	CHF 504.2m	CHF 77.25	PS3.4x	E22.0%	0%
ADXN Addex Therapeutics	CHF 0.06	0%	32.2%	CHF 5.9m	CHF 0.16	PS10x	E0.09%	n/a
LONN Lonza Group	CHF 528.20	-3.6%	52.5%	CHF 39.0b	CHF 636.90	PE66.6x	E23.4%	0.8%
SANN Santhera Pharmaceuticals Holding	CHF 9.98	4.2%	-1.8%	CHF 120.8m	CHF 32.00	PE1.9x	E35.4%	n/a
OBSN ObsEva	CHF 0.0012	0%	-98.2%	CHF 140.6k	n/a	PE0.02x	n/a	n/a
PPGN PolyPeptide Group	CHF 29.25	5.4%	75.7%	CHF 964.8m	CHF 36.25	PS3.2x	E64.2%	0%
RLF Relief Therapeutics Holding	CHF 4.03	1.3%	129.0%	CHF 50.5m	n/a	PS5.9x	n/a	n/a
NOVN Novartis	CHF 87.04	-1.2%	3.3%	CHF 174.0b	CHF 103.61	PE16.4x	E7.0%	3.7%
GALD Galderma Group	CHF 96.20	6.6%	n/a	CHF 22.9b	CHF 99.88	PS5.9x	E44.6%	n/a
SFZN Siegfried Holding	CHF 974.00	-7.8%	15.7%	CHF 4.2b	CHF 1,187.67	PE32.4x	E13.7%	0.4%

Page 1 of 1